These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 26905607)
21. Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma. La Mura V; De Renzo A; Perna F; D'Agostino D; Masarone M; Romano M; Bruno S; Torella R; Persico M J Hepatol; 2008 Oct; 49(4):557-63. PubMed ID: 18678434 [TBL] [Abstract][Full Text] [Related]
22. Non-Hodgkin lymphoma and hepatitis C: where we are and what next? Sulyok M; Makara M; Újhelyi E; Vályi-Nagy I Pathol Oncol Res; 2015 Jan; 21(1):1-7. PubMed ID: 25273531 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage. Zuckerman E; Zuckerman T Blood Rev; 2002 Jun; 16(2):119-25. PubMed ID: 12127955 [TBL] [Abstract][Full Text] [Related]
24. HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens. Marignani M; Mangone M; Cox MC; Angeletti S; Veggia B; Ferrari A; di Fonzo M; Begini P; Gigante E; Laverde G; Aloe-Spiriti A; Monarca B; Delle Fave G Dig Liver Dis; 2011 Feb; 43(2):139-42. PubMed ID: 20554488 [TBL] [Abstract][Full Text] [Related]
25. Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa. Levine AM; Shimodaira S; Lai MM N Engl J Med; 2003 Nov; 349(21):2078-9. PubMed ID: 14627800 [No Abstract] [Full Text] [Related]
27. Hepatitis C virus and lymphoma. Paydas S Crit Rev Oncol Hematol; 2015 Mar; 93(3):246-56. PubMed ID: 25457774 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis C infection and lymphomas: is there any benefit in viral treatment? Bruni L; De Sanjose S Gastroenterology; 2006 Aug; 131(2):685-6; author reply 686-7. PubMed ID: 16890632 [No Abstract] [Full Text] [Related]
29. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ; Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699 [TBL] [Abstract][Full Text] [Related]
30. Role of hepatitis C virus infection in malignant lymphoma in Spain. de Sanjose S; Nieters A; Goedert JJ; Domingo-Domenech E; Fernandez de Sevilla A; Bosch R; Herrera P; Domingo A; Petit J; Bosch X; Kallinowski B Int J Cancer; 2004 Aug; 111(1):81-5. PubMed ID: 15185347 [TBL] [Abstract][Full Text] [Related]
31. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders. Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535 [TBL] [Abstract][Full Text] [Related]
32. Hepatitis C cure with antiviral therapy--benefits beyond the liver. Soriano V; Labarga P; Fernandez-Montero JV; de Mendoza C; Esposito I; Benítez-Gutiérrez L; Barreiro P Antivir Ther; 2016; 21(1):1-8. PubMed ID: 26110692 [TBL] [Abstract][Full Text] [Related]
33. The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study. Giannoulis E; Economopoulos T; Mandraveli K; Giannoulis K; Nikolaides C; Zervou E; Papageorgiou E; Zoulas D; Tourkantonis A; Giannopoulos G; Fountzilas G; Acta Haematol; 2004; 112(4):189-93. PubMed ID: 15564729 [TBL] [Abstract][Full Text] [Related]
34. Rapid Resolution of Hepatitis C Virus-Associated Cryoglobulin Rash With Use of Direct-Acting Antivirals. Chak E; Schulze C; Runyon BA Clin Gastroenterol Hepatol; 2015 Nov; 13(11):e166-7. PubMed ID: 25862985 [No Abstract] [Full Text] [Related]
35. Hepatitis C in 2013: HCV causes systemic disorders that can be cured. Negro F Nat Rev Gastroenterol Hepatol; 2014 Feb; 11(2):77-8. PubMed ID: 24275792 [TBL] [Abstract][Full Text] [Related]
37. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189 [TBL] [Abstract][Full Text] [Related]
38. Regression of low-grade non-Hodgkin's lymphoma after treatment with pegylated interferon plus ribavirin in hepatitis C virus infection. Mazzaro C; Spina M; Tirelli U J Clin Oncol; 2005 Jul; 23(19):4470-1; author reply 4471. PubMed ID: 15994165 [No Abstract] [Full Text] [Related]
39. [Successful treatment of severe HCV-cryoglobulinemic vasculitis with the use of CD20 monoclonalantibodies and antiviral agents]. Ignatova TM; Chernova OA; Burnevich EZ; Milovanova SIu Klin Med (Mosk); 2014; 92(8):62-4. PubMed ID: 25790700 [TBL] [Abstract][Full Text] [Related]
40. Extrahepatic Manifestations of Hepatitis C Virus. Viganò M; Colombo M Gastroenterol Clin North Am; 2015 Dec; 44(4):775-91. PubMed ID: 26600219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]